Literature DB >> 21683973

Transgenic expression of full-length 2',5'-oligoadenylate synthetase 1b confers to BALB/c mice resistance against West Nile virus-induced encephalitis.

Dominique Simon-Chazottes1, Marie-Pascale Frenkiel, Xavier Montagutelli, Jean-Louis Guénet, Philippe Desprès, Jean-Jacques Panthier.   

Abstract

Susceptibility of inbred strains to infection with West Nile virus (WNV) has been genetically associated with an arginine-to-a nonsense codon substitution at position 253 (R253X) in the predicted sequence of the murine 2',5'-oligoadenylate synthetase 1B (OAS1B) protein. We introduced by transgenesis the Oas1b cDNA from MBT/Pas mice carrying the R253 codon (Oas1b(MBT)) into BALB/c mice homozygous for the X253 allele (Oas1b(BALB/c)). Overexpression of Oas1b(MBT) mRNA in the brain of transgenic mice prior and in the time course of infection provided protection against the neuroinvasive WNV strain IS-98-ST1. A 200-fold induction of Oas1b(MBT) mRNA in the brain of congenic BALB/c mice homozygous for a MBT/Pas segment encompassing the Oas1b gene was also efficient in reducing both viral growth and mortality, whereas a 200-fold induction of Oas1b(BALB/c) mRNA was unable to prevent virally-induced encephalitis, confirming the critical role of the R253X mutation on Oas1b activity in live mice.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21683973     DOI: 10.1016/j.virol.2011.05.018

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  The interferon-inducible gene viperin restricts West Nile virus pathogenesis.

Authors:  Kristy J Szretter; James D Brien; Larissa B Thackray; Herbert W Virgin; Peter Cresswell; Michael S Diamond
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

2.  RNase L Antiviral Activity Is Not a Critical Component of the Oas1b-Mediated Flavivirus Resistance Phenotype.

Authors:  J C Madden; Dan Cui; M A Brinton
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

Review 3.  Controlling complexity: the clinical relevance of mouse complex genetics.

Authors:  Klaus Schughart; Claude Libert; Martien J Kas
Journal:  Eur J Hum Genet       Date:  2013-05-01       Impact factor: 4.246

Review 4.  Host genetic control of mosquito-borne Flavivirus infections.

Authors:  Caroline Manet; Claude Roth; Ahmed Tawfik; Tineke Cantaert; Anavaj Sakuntabhai; Xavier Montagutelli
Journal:  Mamm Genome       Date:  2018-08-25       Impact factor: 2.957

5.  Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes.

Authors:  Jessica B Graham; Sunil Thomas; Jessica Swarts; Aimee A McMillan; Martin T Ferris; Mehul S Suthar; Piper M Treuting; Renee Ireton; Michael Gale; Jennifer M Lund
Journal:  MBio       Date:  2015-05-05       Impact factor: 7.867

6.  A Mouse Model of Chronic West Nile Virus Disease.

Authors:  Jessica B Graham; Jessica L Swarts; Courtney Wilkins; Sunil Thomas; Richard Green; Aimee Sekine; Kathleen M Voss; Renee C Ireton; Michael Mooney; Gabrielle Choonoo; Darla R Miller; Piper M Treuting; Fernando Pardo Manuel de Villena; Martin T Ferris; Shannon McWeeney; Michael Gale; Jennifer M Lund
Journal:  PLoS Pathog       Date:  2016-11-02       Impact factor: 6.823

7.  IS-98-ST1 West Nile virus derived from an infectious cDNA clone retains neuroinvasiveness and neurovirulence properties of the original virus.

Authors:  Céline Bahuon; Philippe Desprès; Nathalie Pardigon; Jean-Jacques Panthier; Nathalie Cordonnier; Steeve Lowenski; Jennifer Richardson; Stéphan Zientara; Sylvie Lecollinet
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

Review 8.  Quantitative genetics in the study of virus-induced disease.

Authors:  Martin T Ferris; Mark T Heise
Journal:  Adv Virus Res       Date:  2014       Impact factor: 9.937

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.